IBNAX
Price
$24.02
Change
+$0.15 (+0.63%)
Updated
Jan 17 closing price
Net Assets
1.54B
RLBCX
Price
$34.77
Change
+$0.21 (+0.61%)
Updated
Jan 17 closing price
Net Assets
238.66B
Ad is loading...

IBNAX vs RLBCX

Header iconIBNAX vs RLBCX Comparison
Open Charts IBNAX vs RLBCXBanner chart's image
Macquarie Balanced Fund
Price$24.02
Change+$0.15 (+0.63%)
VolumeN/A
Net Assets1.54B
American Funds American Balanced R3
Price$34.77
Change+$0.21 (+0.61%)
VolumeN/A
Net Assets238.66B
IBNAX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IBNAX vs. RLBCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNAX is a Hold and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 239B vs. IBNAX (1.54B). IBNAX (2.06) and RLBCX (1.98) have matching dividends . IBNAX was incepted earlier than RLBCX: IBNAX (37 years) vs RLBCX (23 years). RLBCX is a more actively managed with annual turnover of: 171.00 vs. IBNAX (82.00). RLBCX has a lower initial minimum investment than IBNAX: RLBCX (250) vs IBNAX (1000). IBNAX annual gain was more profitable for investors over the last year : 18.51 vs. RLBCX (11.92). RLBCX return over 5 years is better than : 28.12 vs. IBNAX (1.40).
IBNAXRLBCXIBNAX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years23 years-
Gain YTD1.9521.935101%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.54B239B1%
Annual Yield % from dividends2.061.98104%
Returns for 1 year18.5111.92155%
Returns for 3 years-3.7111.58-32%
Returns for 5 years1.4028.125%
Returns for 10 years6.3853.4112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSS13.000.15
+1.17%
Kohls Corp
GGB2.830.01
+0.35%
Gerdau SA
EW69.78-0.08
-0.11%
Edwards Lifesciences Corp
CTSO1.03-0.01
-0.96%
Cytosorbents Corp
GLUE5.66-0.11
-1.82%
Monte Rosa Therapeutics